ADC-19095-74253 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Dose 1 — Pfizer-BioNTech
2020-12-22
Registered in v-safe
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-04
Survey response — day 14, dose 1
MedDRA: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth — Feeling: Good

Free text: 8 days after the vaccine developed localized redness, swelling, warmth, and itching at the vaccine site. Had no local reaction until this happened after 8 days

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-11
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-12
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-08
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-12
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-12
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-05
Dose 3 — Pfizer-BioNTech
2021-09-29
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-10-03
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-10-12
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-10-17
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-12-05
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech
3	2021-09-05	Pfizer-BioNTech	No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 14, dose 1

2021-01-04

Symptoms: 8 days after the vaccine developed localized redness, swelling, warmth, and itching at the vaccine site. Had no local reaction until this happened after 8 days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Injection site erythema	○	○	○
SD	Injection site pruritus	○	○	○
SD	Injection site swelling	○	○	○
SD	Injection site warmth	○	○	○
SD	Vaccination site erythema	✓	✓	✓
SD	Vaccination site pruritus	✓	✓	✓
SD	Vaccination site swelling	✓	✓	✓
SD	Vaccination site warmth	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release